NCT01568489View on ClinicalTrials.gov

Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic Dermatitis

PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

April 9, 2012

Primary Completion Date

June 11, 2013

Study Completion Date

June 11, 2013

Conditions
Mild to Moderate Atopic Dermatitis
Interventions
DRUG

HL-009 Liposomal Gel

Topical adenosylcobalamin gel

DRUG

Placebo

Placebo gel

Trial Locations (7)

27157

Winston-Salem

44118

South Euclid

55432

Fridley

60025

Arlington Heights

78759

Austin

97223

Portland

08009

Berlin

Sponsors
All Listed Sponsors
lead

HanAll BioPharma Co., Ltd.

INDUSTRY